Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of antifungal combination against Cryptococcus spp.

Mycoses - 1 Sept 2016

Reichert-Lima Franqueline, Busso-Lopes Ariane F, Lyra Luzia, Peron Isabela Haddad, Taguchi Hideaki, Mikami Yuzuru, Kamei Katsuiko, Moretti Maria Luiza, Schreiber Angelica Z

Abstract excerpt

The second cause of death among systemic mycoses, cryptococcosis treatment represents a challenge since that 5-flucytosine is not currently available in Brazil. Looking for alternatives, this study evaluated antifungal agents, alone and combined, correlating susceptibility to genotypes. Eighty Cryptococcus clinical isolates were genotyped by URA5 gene restriction fragment length polymorphism. Antifungal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amphotericin B
Share to Cryptococcosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cryptococcus

Share to Cryptococcus neoformans

Share to Fluconazole

Share to Itraconazole

Share to Naphthalenes

Share to Voriconazole

Source

Identifiers

PMID: 27135278
DOI: 10.1111/myc.12510

Genes

TRB

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of antifungal combination against Cryptococcus spp.PMID 27135278Read ↗

Molecular epidemiology and antifungal susceptibility profiles of clinical Cryptococcus neoformans/Cryptococcus gattii species complexSemantic proximity Read ↗

Genetic diversity and antifungal susceptibilities of environmental Cryptococcus neoformans and Cryptococcus gattii species complexesSemantic proximity Read ↗

Molecular characterisation and antifungal susceptibility of clinical Cryptococcus deuterogattii (AFLP6/VGII) isolates from Southern Brazil.Semantic proximity Read ↗

Antifungal susceptibility and molecular characteristics of Cryptococcus spp. based on whole-genome sequencing in Zhejiang Province, ChinaSemantic proximity Read ↗

Correlation of antifungal susceptibility and molecular type within the Cryptococcus neoformans/C. gattii species complex.Semantic proximity Read ↗

Epidemiological trends of cryptococcosis in Italy: Molecular typing and susceptibility pattern of Cryptococcus neoformans isolates collected during a 20-year period.Semantic proximity Read ↗

Diversity and Antifungal Drug Susceptibility of Cryptococcus Isolates in Thailand.Semantic proximity Read ↗

Genotypic diversity of Iranian Cryptococcus neoformans using multilocus sequence typing (MLST) and susceptibility to antifungals.Semantic proximity Read ↗

Antifungal susceptibility of clinical Cryptococcus gattii isolates from Colombia varies among molecular types.Semantic proximity Read ↗

Microbiological, Epidemiological, and Clinical Characteristics of Patients With Cryptococcal Meningitis at a Tertiary Hospital in China: A 6-Year Retrospective AnalysisSemantic proximity Read ↗

Comparison of Cryptococcus gattii/neoformans Species Complex to Related Genera (Papiliotrema and Naganishia) Reveal Variances in Virulence Associated Factors and Antifungal SusceptibilitySemantic proximity Read ↗

Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.